Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?
Here is how Agilon Health (AGL) and Amarin (AMRN) have performed compared to their sector so far this year.
agilon health, inc. (AGL) Q1 2026 Earnings Call Transcript
agilon health, inc. (AGL) Q1 2026 Earnings Call Transcript
Agilon Health (AGL) Q1 Earnings and Revenues Top Estimates
Agilon Health (AGL) came out with quarterly earnings of $1.8 per share, beating the Zacks Consensus Estimate of $1.13 per share. This compares to break-even earnings per share a year ago.
Agilon (AGL) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Australia's AGL Energy lifts lower end of fiscal 2026 earnings outlook
Australia's AGL Energy on Wednesday raised the lower end of its full-year profit forecast, helped by the continued strong operational and financial performance of its business since its last update in February.
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Here is how Agilon Health (AGL) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
agilon health's Vitals Are Improving (Upgrade)
agilon health is rated a cautious 'Hold' as management executes a strategic downsizing to address persistent losses. Recent exits from underperforming markets and partnerships are expected to improve medical margin from -$56.6 million in 2025 to $325 million in 2026. Despite revenue and membership declines, AGL guides for near break-even EBITDA in 2026, a significant improvement from -$296.2 million prior.
Capital International Investors Has $8.48 Million Stake in Agilon Health, Inc. $AGL
Capital International Investors decreased its stake in shares of Agilon Health, Inc. (NYSE: AGL) by 16.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 8,232,209 shares of the company's stock after selling 1,660,533 shares during the period. Capital International Investors owned 1.99%
agilon health, inc. (AGL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
agilon health, inc. (AGL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Compared to Estimates, Agilon (AGL) Q4 Earnings: A Look at Key Metrics
The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Australia's AGL Energy narrows full-year earnings outlook, first-half profit falls 6%
Australian power producer AGL Energy narrowed its full-year earnings forecast on Wednesday, citing higher consumer margin and lower costs, while reporting a 6.4% fall in its first-half underlying profit.
agilon health, inc. (AGL) Q3 2025 Earnings Call Transcript
agilon health, inc. ( AGL ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Evan Smith - Senior Vice President of Investor Relations Ronald Williams - Executive Chairman Jeffrey Schwaneke - Executive VP & CFO Conference Call Participants Hua Ha - Robert W.
